drugset / Trial / NCT04494880

Marcaine Post-Operative Pain Study

NCT04494880

RandomizedParallel-groupDouble-blindTreatment

Summary

The study examines the efficacy of Marcaine in post-operative pain reduction for patients receiving breast reduction surgery. Patients who consent will be randomized to which breast receives a Marcaine injection and the other breast will have saline injected. Pain will be assessed one time post-operatively using a 1-10 pain scale.

Timeline

Start
2020-12-09
Primary completion
2022-12-01
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified Other

Indications

No indication recorded.